NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 43 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is 5.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $14,000 | -78.8% | 26,597 | -47.0% | 0.00% | – |
| Q4 2019 | $66,000 | – | 50,186 | +1254550.0% | 0.00% | – |
| Q3 2019 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q1 2019 | $212,000 | +10500.0% | 86,904 | +5791.8% | 0.00% | – |
| Q4 2018 | $2,000 | -92.3% | 1,475 | -84.6% | 0.00% | – |
| Q3 2018 | $26,000 | -64.9% | 9,548 | -55.4% | 0.00% | – |
| Q2 2018 | $74,000 | +111.4% | 21,419 | +199.1% | 0.00% | – |
| Q1 2018 | $35,000 | -93.0% | 7,162 | -91.4% | 0.00% | – |
| Q4 2017 | $499,000 | -26.5% | 83,610 | +0.8% | 0.00% | – |
| Q3 2017 | $679,000 | +62.8% | 82,985 | +108.0% | 0.00% | – |
| Q2 2017 | $417,000 | – | 39,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,074,190 | $33,368,000 | 6.74% |
| Novo Holdings A/S | 2,903,800 | $23,782,000 | 3.10% |
| PURA VIDA INVESTMENTS, LLC | 425,000 | $3,481,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $3,276,000 | 0.59% |
| Monashee Investment Management LLC | 188,000 | $1,540,000 | 0.58% |
| Orbimed Advisors | 3,919,600 | $32,102,000 | 0.31% |
| FT Options LLC | 20,000 | $164,000 | 0.25% |
| Rock Springs Capital Management LP | 625,000 | $5,119,000 | 0.24% |
| Rubric Capital Management LP | 300,000 | $2,457,000 | 0.22% |
| Ghost Tree Capital, LLC | 120,000 | $983,000 | 0.21% |